Latest period
$72.86B
YoY change
+1.8%
5Y CAGR
-4.5%
Peak year (2020)
$87.06B
Latest annual
$69.07B
Total Debt history chart for AbbVie (ABBV) from 2010 to 2025
Latest: $69.07B
Total Debt growth chart for AbbVie (ABBV) from 2010 to 2025
Latest: +1.8%
Total Debt history table for AbbVie (ABBV) from 2010 to 2025
| 2025 | $69.07B | +1.8% | +$1.23B | ||
| 2024 | $67.84B | +12.8% | +$7.72B | ||
| 2023 | $60.12B | -6.3% | −$4.07B | ||
| 2022 | $64.19B | -17.3% | −$13.38B | ||
| 2021 | $77.58B | -10.9% | −$9.49B | ||
| 2020 | $87.06B | +29.8% | +$19.98B | ||
| 2019 | $67.09B | +66.4% | +$26.78B | ||
| 2018 | $40.31B | +7.9% | +$2.94B | ||
| 2017 | $37.37B | +1.4% | +$526.00M | ||
| 2016 | $36.84B | +16.3% | +$5.17B | ||
| 2015 | $31.67B | +111.0% | +$16.66B | ||
| 2014 | $15.01B | +2.0% | +$288.00M | ||
| 2013 | $14.72B | -6.1% | −$949.00M | ||
| 2012 | $15.67B | — | +$15.67B | ||
| 2011 | $0.00 | — | $0.00 | ||
| 2010 | $0.00 | — | — |
- 2025$69.07B+1.8%
- 2024$67.84B+12.8%
- 2023$60.12B-6.3%
- 2022$64.19B-17.3%
- 2021$77.58B-10.9%
- 2020$87.06B+29.8%
- 2019$67.09B+66.4%
- 2018$40.31B+7.9%
- 2017$37.37B+1.4%
- 2016$36.84B+16.3%
- 2015$31.67B+111.0%
- 2014$15.01B+2.0%
- 2013$14.72B-6.1%
- 2012$15.67B—
- 2011$0.00—
- 2010$0.00—
Total Debt values are taken from AbbVie's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's latest reported total debt is $72.86B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, AbbVie (ABBV) total debt totalled $69.07B – edged up 1.8% year-over-year.
Across 2020–2025 (5 years), AbbVie total debt produced a CAGR of -4.5% – with a net decline across the window.
The record annual total debt stands at $87.06B, reached in 2020; the historical low of $0.00 was recorded in 2010.
AbbVie Total Debt by Year
AbbVie Total Debt 2025: $69.07B
AbbVie posted total debt of $69.07B in 2025, edged up 1.8% from 2024.
AbbVie Total Debt 2024: $67.84B
In 2024, AbbVie reported total debt of $67.84B, grew 12.8% from 2023.
AbbVie Total Debt 2023: $60.12B
AbbVie total debt in 2023 was $60.12B, declined 6.3% below 2022.
AbbVie Total Debt 2022: $64.19B
2022's total debt for AbbVie came in at $64.19B, declined 17.3% below 2021.
AbbVie Total Debt 2021: $77.58B
AbbVie total debt in 2021 was $77.58B.
See more financial history for AbbVie (ABBV).
Sector peers by Total Debt
Healthcare peers of AbbVie (ABBV), ranked by their latest total debt
| $78.39B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $40.85B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $54.60B
- $50.53B
- $47.93B
- $42.50B
- $29.70B
- $20.59B
Frequently asked questions
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation